Hyperion Trading Segregated Portfolio

10% owner at TorreyPines Therapeutics, Inc.

Sold, on record
$22.5M
Dollars the filings state
Form 4 sales
4
Latest Aug 23, 2013
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale TorreyPines Therapeutics, Inc.Unusual
    Jun 13, 2012 2012

    Sold 2.4M shares at $5.44 ($13.1M)

    Hyperion Trading Segregated Portfolio, 10% owner

    Sold 49% of holdings ($26.7M position)2.5M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale TorreyPines Therapeutics, Inc.Plan not stated
    Apr 5, 2013 +296 days

    Sold 243,961 shares at $5.77 ($1.4M)

    Hyperion Trading Segregated Portfolio, 10% owner

    Sold 3.5% of holdings ($40.1M position)6.7M shares leftFiling

  3. 3 Form 4 sale TorreyPines Therapeutics, Inc.Plan not stated
    Aug 13, 2013 +130 days

    Sold 616,536 shares at $7.44 ($4.6M)

    Hyperion Trading Segregated Portfolio, 10% owner

    Sold 9% of holdings ($51M position)6.2M shares leftFiling

  4. 4 Form 4 sale TorreyPines Therapeutics, Inc.Plan not stated
    Aug 23, 2013 +10 days

    Sold 279,300 shares at $12.31 ($3.4M)

    Hyperion Trading Segregated Portfolio, 10% owner

    Sold 4.5% of holdings ($76.8M position)6M shares left0.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Hyperion Trading Segregated Portfolio
Source
Aug 23, 2013Oct 3, 2014TorreyPines Therapeutics, Inc.10% ownerForm 4 sale279,300$3.4M4.5%Plan not statedSEC
Aug 13, 2013Oct 3, 2014TorreyPines Therapeutics, Inc.10% ownerForm 4 sale616,536$4.6M9.0%Plan not statedSEC
Apr 5, 2013Oct 3, 2014TorreyPines Therapeutics, Inc.10% ownerForm 4 sale243,961$1.4M3.5%Plan not statedSEC
Jun 13, 2012Oct 3, 2014TorreyPines Therapeutics, Inc.10% ownerForm 4 sale2.4M$13.1M49.0%UnusualSEC